Structure-activity relationships for euphocharacins A-L, a new series of jatrophane diterpenes, as inhibitors of cancer cell P-glycoprotein

被引:33
|
作者
Corea, G
Fattorusso, E
Lanzotti, V
Motti, R
Simon, PN
Dumontet, C
Di Pietro, A
机构
[1] Univ Molise, DISTAAM, I-86100 Campobasso, Italy
[2] Univ Naples Federico II, Dipartimento Chim Sostanze Nat, Naples, Italy
[3] Univ Naples Federico II, Dipartimento Arboricoltura Bot & Patol Vegetale, Portici, NA, Italy
[4] INSERM, U590, F-69008 Lyon, France
[5] Univ Lyon 1, CNRS, UMR 5086, Inst Biol & Chim Prot, Lyon, France
[6] BioSci Lyon Gerland, IFR 128, Lyon, France
关键词
Euphorbiaceae; Euphorbia characias; diterpenes; jatrophanes; P-glycoprotein; SAR studies;
D O I
10.1055/s-2004-827191
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
The Mediterranean spurge Euphorbia characias L. afforded twelve new diterpenes based on a jatrophane skeleton named euphocharacins A - L. Their chemical structures were elucidated by extensive nuclear magnetic resonance and mass spectrometry methods. Euphocharacins A-L were tested as inhibitors of the daunomycin-efflux activity of P-glycoprotein from cancer cells. The results were used to extend the structure-activity relationship established for this class of compounds, highlighting the positive effects of propyl and benzoyl groups at positions 3 and 9, respectively, and evidencing the negative effect of a free hydroxyl group at position 2. Among the tested compounds, euphocharacins C and I showed an activity higher than cyclosporin to inhibit Pgp-mediated daunomycin transport.
引用
收藏
页码:657 / 665
页数:9
相关论文
共 50 条
  • [1] Jatrophane diterpenes as P-glycoprotein inhibitors. First insights of structure-activity relationships and discovery of a new, powerful lead
    Corea, G
    Fattorusso, E
    Lanzotti, V
    Taglialatela-Scafati, O
    Appendino, G
    Ballero, M
    Simon, PN
    Dumontet, C
    Di Pietro, A
    JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (15) : 3395 - 3402
  • [2] Discovery of a new series of jatrophane and lathyrane diterpenes as potent and specific P-glycoprotein modulators
    Barile, Elisa
    Borriello, Marianna
    Di Pietro, Attilio
    Doreau, Agnes
    Fattorusso, Caterina
    Fattorusso, Ernesto
    Lanzotti, Virginia
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2008, 6 (10) : 1756 - 1762
  • [3] Functional assay and structure-activity relationships of new third-generation P-glycoprotein inhibitors
    Mueller, Henrik
    Pajeva, Ilza K.
    Globisch, Christoph
    Wiese, Michael
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (05) : 2448 - 2462
  • [4] Three-dimensional quantitative structure-activity relationships of inhibitors of P-glycoprotein
    Ekins, S
    Kim, RB
    Leake, BF
    Dantzig, AH
    Schuetz, EG
    Lan, LB
    Yasuda, K
    Shepard, RL
    Winter, MA
    Schuetz, JD
    Wikel, JH
    Wrighton, SA
    MOLECULAR PHARMACOLOGY, 2002, 61 (05) : 964 - 973
  • [5] Requirements for P-glycoprotein recognition based on structure-activity relationships in the podophyllotoxin series
    Etievant, C
    Schambel, P
    Guminski, Y
    Barret, JM
    Imbert, T
    Hill, BT
    ANTI-CANCER DRUG DESIGN, 1998, 13 (04): : 317 - 336
  • [6] Progress in understanding the structure-activity relationships of P-glycoprotein
    Stouch, TR
    Gudmundsson, A
    ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (03) : 315 - 328
  • [7] Analysis of structure-activity relationships of P-glycoprotein mediators for development of a new P-glycoprotein inhibitor: Pyronaridine.
    Yang, CZ
    Qi, J
    Wang, SB
    Peng, H
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U481 - U481
  • [8] Structure-activity relationships and in silico models of P-glycoprotein (ABCB1) inhibitors
    Liu, Hongming
    Ma, Zhiguo
    Wu, Baojian
    XENOBIOTICA, 2013, 43 (11) : 1018 - 1026
  • [9] P-GLYCOPROTEIN AND MULTIDRUG RESISTANCE: STRUCTURE-ACTIVITY RELATIONSHIPS OF MODULATORS
    Huber, Paula C.
    Maruiama, Cintia H.
    Almeida, Wanda P.
    QUIMICA NOVA, 2010, 33 (10): : 2148 - 2154
  • [10] Structure-activity relationship: analyses of p-glycoprotein substrates and inhibitors
    Wang, RB
    Kuo, CL
    Lien, LL
    Lien, EJ
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2003, 28 (03) : 203 - 228